首页 > 最新文献

Revista Peruana de Medicina de Experimental y Salud Publica最新文献

英文 中文
Isolation of Escherichia coli with a combination of carbapenemases (bla NDM +bla OXA-48-like ) in a hospital in Huancavelica, Peru. 秘鲁万卡维利卡某医院碳青霉烯酶(bla NDM +bla oxa -48样)联合大肠杆菌的分离
IF 1 Q3 Medicine Pub Date : 2025-12-01 DOI: 10.17843/rpmesp.2025.423.14193
Dany Victorio-López, Wendi Pompilio, Jhonatan Carrera-Donayre, Juan Ramírez-Illescas, Raquel Maraza-Huarachi, Maritza Mayta-Barrios, Diana Flores-León, Martin Yagui, Luis Pampa-Espinoza
{"title":"Isolation of Escherichia coli with a combination of carbapenemases (bla NDM +bla OXA-48-like ) in a hospital in Huancavelica, Peru.","authors":"Dany Victorio-López, Wendi Pompilio, Jhonatan Carrera-Donayre, Juan Ramírez-Illescas, Raquel Maraza-Huarachi, Maritza Mayta-Barrios, Diana Flores-León, Martin Yagui, Luis Pampa-Espinoza","doi":"10.17843/rpmesp.2025.423.14193","DOIUrl":"10.17843/rpmesp.2025.423.14193","url":null,"abstract":"","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"42 3","pages":"333-335"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679978/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Years of potential life lost due to drug-susceptible pulmonary tuberculosis in Cali, Colombia, 2009-2020. 2009-2020年哥伦比亚卡利市因药敏肺结核可能损失的生命年数。
IF 1 Q3 Medicine Pub Date : 2025-12-01 DOI: 10.17843/rpmesp.2025.423.14207
Adriana M Rivas-Mina, Jose F Fuertes-Bucheli, Jennifer Lozano-García, Laura D Luna, Yessenia Niño-Ramiréz, Lucy Luna, Robinson Pacheco López

A cross-sectional descriptive and analytical study evaluated years of potential life lost (YPLL) due to drug-susceptible pulmonary tuberculosis in Cali from 2009 to 2020, using death records from the Health Secretariat. Total YPLL and its annual rate were calculated by age at death, and median YPLL values were compared across subgroups. A total of 565 registers of death records were analyzed (71.5% men; median age 56 years, range 38-70), yielding 11,238 YPLL. The highest median YPLL were observed among persons living with HIV, those in socially vulnerable situations, the uninsured or those under subsidized or special coverage, in women, and in those who re-entered after previously discontinuing treatment or experiencing a tuberculosis relapse.

一项横断面描述性和分析性研究利用卫生秘书处的死亡记录,评估了2009年至2020年卡利市因药物敏感肺结核导致的潜在生命损失年数。按死亡年龄计算总YPLL及其年发生率,并比较各亚组间YPLL值的中位数。共分析了565份死亡记录(71.5%为男性,中位年龄56岁,范围38-70岁),得到11,238例YPLL。在艾滋病毒感染者、社会弱势群体、无保险或有补贴或特殊保险的人群、妇女以及先前停止治疗或结核病复发后重新进入的人群中,观察到最高的中位数YPLL。
{"title":"Years of potential life lost due to drug-susceptible pulmonary tuberculosis in Cali, Colombia, 2009-2020.","authors":"Adriana M Rivas-Mina, Jose F Fuertes-Bucheli, Jennifer Lozano-García, Laura D Luna, Yessenia Niño-Ramiréz, Lucy Luna, Robinson Pacheco López","doi":"10.17843/rpmesp.2025.423.14207","DOIUrl":"10.17843/rpmesp.2025.423.14207","url":null,"abstract":"<p><p>A cross-sectional descriptive and analytical study evaluated years of potential life lost (YPLL) due to drug-susceptible pulmonary tuberculosis in Cali from 2009 to 2020, using death records from the Health Secretariat. Total YPLL and its annual rate were calculated by age at death, and median YPLL values were compared across subgroups. A total of 565 registers of death records were analyzed (71.5% men; median age 56 years, range 38-70), yielding 11,238 YPLL. The highest median YPLL were observed among persons living with HIV, those in socially vulnerable situations, the uninsured or those under subsidized or special coverage, in women, and in those who re-entered after previously discontinuing treatment or experiencing a tuberculosis relapse.</p>","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"42 3","pages":"300-306"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679976/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Homicides in Peru: the importance of accurate and timely recording of causes of death. 秘鲁的杀人案:准确和及时记录死因的重要性。
IF 1 Q3 Medicine Pub Date : 2025-12-01 DOI: 10.17843/rpmesp.2025.423.14947
Akram Hernández-Vásquez, Luis Ttito-Paricahua, Richard Asmat-Condormango, Judith Quiñones-Inga
{"title":"Homicides in Peru: the importance of accurate and timely recording of causes of death.","authors":"Akram Hernández-Vásquez, Luis Ttito-Paricahua, Richard Asmat-Condormango, Judith Quiñones-Inga","doi":"10.17843/rpmesp.2025.423.14947","DOIUrl":"10.17843/rpmesp.2025.423.14947","url":null,"abstract":"","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"42 3","pages":"328-330"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679969/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resistance to colistin and fosfomycin in extended-spectrum beta-lactamase-producing Escherichia coli. 广谱β -内酰胺酶产生大肠杆菌对粘菌素和磷霉素的耐药性。
IF 1 Q3 Medicine Pub Date : 2025-12-01 DOI: 10.17843/rpmesp.2025.423.14482
Ana Paula Roldan-Galarreta, Maria Fernanda Arce-Servat, Franco Arancivia-Neira, Edgar Gonzales-Escalante

The objective of our study was to determine the resistance to colistin and fosfomycin of extended-spectrum beta-lactamase-producing Escherichia coli (Ec-BLEE). We conducted a cross-sectional descriptive study in which we analyzed 79 isolates of Ec-BLEE obtained from a previous study involving 300 chicken cloacal swab samples. We processed the isolates in the Microbiology and Immunology Laboratory of the Faculty of Medicine of the Universidad de Piura, Lima-Peru. We determined the sensitivity to colistin with the Colistin-AgarSpot detection medium and the sensitivity to fosfomycin by antibiogram according to the CLSI guidelines. We searched for the mcr-1 and fosA3 genes through PCR. We found a resistance to colistin in 17,7% and to fosfomycin in 77% of the samples. We did not detect the mcr-1 gene in the colistin-resistant isolates. The fosA3 gene was present in 100% of the fosfomycin resistant isolates.

本研究的目的是测定广谱β -内酰胺酶产生大肠杆菌(Ec-BLEE)对粘菌素和磷霉素的耐药性。我们进行了一项横断面描述性研究,分析了从之前的研究中获得的79株Ec-BLEE分离株,该研究涉及300只鸡的肛肠拭子样本。我们在秘鲁利马皮乌拉大学医学院微生物学和免疫学实验室对分离株进行了处理。采用粘菌素- agarspot检测培养基测定其对粘菌素的敏感性,采用抗生素谱法测定其对磷霉素的敏感性。我们通过PCR寻找mcr-1和fosA3基因。我们发现17.7%的样本对粘菌素耐药,77%的样本对磷霉素耐药。我们未在耐粘菌素的分离株中检测到mcr-1基因。fosA3基因存在于100%的耐磷菌株中。
{"title":"Resistance to colistin and fosfomycin in extended-spectrum beta-lactamase-producing Escherichia coli.","authors":"Ana Paula Roldan-Galarreta, Maria Fernanda Arce-Servat, Franco Arancivia-Neira, Edgar Gonzales-Escalante","doi":"10.17843/rpmesp.2025.423.14482","DOIUrl":"10.17843/rpmesp.2025.423.14482","url":null,"abstract":"<p><p>The objective of our study was to determine the resistance to colistin and fosfomycin of extended-spectrum beta-lactamase-producing Escherichia coli (Ec-BLEE). We conducted a cross-sectional descriptive study in which we analyzed 79 isolates of Ec-BLEE obtained from a previous study involving 300 chicken cloacal swab samples. We processed the isolates in the Microbiology and Immunology Laboratory of the Faculty of Medicine of the Universidad de Piura, Lima-Peru. We determined the sensitivity to colistin with the Colistin-AgarSpot detection medium and the sensitivity to fosfomycin by antibiogram according to the CLSI guidelines. We searched for the mcr-1 and fosA3 genes through PCR. We found a resistance to colistin in 17,7% and to fosfomycin in 77% of the samples. We did not detect the mcr-1 gene in the colistin-resistant isolates. The fosA3 gene was present in 100% of the fosfomycin resistant isolates.</p>","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"42 3","pages":"307-311"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality and associated factors in post-stem cell transplant patients: a two-year cohort in a public hospital in Peru. 干细胞移植后患者的死亡率及相关因素:秘鲁一家公立医院的两年队列研究
IF 1 Q3 Medicine Pub Date : 2025-12-01 DOI: 10.17843/rpmesp.2025.423.14389
Mario Agramonte-Vilca, Karol Moscol-Chavez, Lourdes Aranda-Gomero, Alfredo Wong-Chang, Stalin Vilcarromero, Cesar Copaja-Corzo

Objective.: To determine mortality and associated factors in patients who received an allogeneic hematopoietic stem cell transplant at the Hospital Nacional Edgardo Rebagliati Martins, between January 2017 and December 2022.

Materials and methods.: A retrospective cohort study was conducted on patients who underwent allogeneic hematopoietic stem cell transplantation (HSCT) between 2017 and 2022. Death at one hundred days and two years, and its associated factors, were evaluated. Proportional Cox regression models were used.

Results.: 342 post-HSCT patients were included, with a median age of 23 years (interquartile range: 10 to 39), of whom 53.5% were women. The most frequent diagnosis for the transplant was acute lymphoblastic leukemia at 54.1%. Mortality in the first 100 days post-HSCT was 8.2%, and at two years was 30.4%. In the multivariate regression at one hundred days, factors associated with a higher risk of mortality were age over 50 years (HRa: 6.97; 95% CI: 1.18-41.23), being a recipient of a haploidentical transplant (HRa: 3.57; 95% CI: 1.13-11.24), and sepsis as a complication (HRa: 68.78; 95% CI: 19.32-244.84). In the two-year analysis, acute myeloid leukemia (1.72; IC 95%: 1.08-2.74), haploidentical transplant (HRa:1.81; 95%CI: 1.21-2.72), and disease relapse (HRa: 4.17; 95%CI%: 2.75-6.31) were associated with a higher risk of death.

Conclusions.: The mortality found was low and similar to that of countries with higher incomes; however, it is necessary to formulate interventions that reduce the incidence of modifiable factors such as sepsis.

目标。目的:确定2017年1月至2022年12月期间在Edgardo Rebagliati Martins医院接受同种异体造血干细胞移植的患者的死亡率和相关因素。材料和方法。对2017年至2022年接受同种异体造血干细胞移植(HSCT)的患者进行回顾性队列研究。评估100天和2岁时的死亡情况及其相关因素。结果:纳入342例hsct后患者,中位年龄为23岁(四分位数范围:10 ~ 39),其中53.5%为女性。移植最常见的诊断是急性淋巴细胞白血病,占54.1%。移植后100天的死亡率为8.2%,两年后的死亡率为30.4%。在100天的多变量回归中,与死亡风险较高相关的因素是年龄超过50岁(HRa: 6.97; 95% CI: 1.18-41.23),接受单倍体移植(HRa: 3.57; 95% CI: 1.13-11.24),败血症作为并发症(HRa: 68.78; 95% CI: 19.32-244.84)。在为期两年的分析中,急性髓系白血病(1.72,IC 95%: 1.08-2.74)、单倍体移植(HRa:1.81, 95% ci: 1.21-2.72)和疾病复发(HRa: 4.17, 95% ci %: 2.75-6.31)与较高的死亡风险相关。结论:发现死亡率较低,与高收入国家相似;然而,有必要制定干预措施,以减少脓毒症等可改变因素的发生率。
{"title":"Mortality and associated factors in post-stem cell transplant patients: a two-year cohort in a public hospital in Peru.","authors":"Mario Agramonte-Vilca, Karol Moscol-Chavez, Lourdes Aranda-Gomero, Alfredo Wong-Chang, Stalin Vilcarromero, Cesar Copaja-Corzo","doi":"10.17843/rpmesp.2025.423.14389","DOIUrl":"10.17843/rpmesp.2025.423.14389","url":null,"abstract":"<p><strong>Objective.: </strong>To determine mortality and associated factors in patients who received an allogeneic hematopoietic stem cell transplant at the Hospital Nacional Edgardo Rebagliati Martins, between January 2017 and December 2022.</p><p><strong>Materials and methods.: </strong>A retrospective cohort study was conducted on patients who underwent allogeneic hematopoietic stem cell transplantation (HSCT) between 2017 and 2022. Death at one hundred days and two years, and its associated factors, were evaluated. Proportional Cox regression models were used.</p><p><strong>Results.: </strong>342 post-HSCT patients were included, with a median age of 23 years (interquartile range: 10 to 39), of whom 53.5% were women. The most frequent diagnosis for the transplant was acute lymphoblastic leukemia at 54.1%. Mortality in the first 100 days post-HSCT was 8.2%, and at two years was 30.4%. In the multivariate regression at one hundred days, factors associated with a higher risk of mortality were age over 50 years (HRa: 6.97; 95% CI: 1.18-41.23), being a recipient of a haploidentical transplant (HRa: 3.57; 95% CI: 1.13-11.24), and sepsis as a complication (HRa: 68.78; 95% CI: 19.32-244.84). In the two-year analysis, acute myeloid leukemia (1.72; IC 95%: 1.08-2.74), haploidentical transplant (HRa:1.81; 95%CI: 1.21-2.72), and disease relapse (HRa: 4.17; 95%CI%: 2.75-6.31) were associated with a higher risk of death.</p><p><strong>Conclusions.: </strong>The mortality found was low and similar to that of countries with higher incomes; however, it is necessary to formulate interventions that reduce the incidence of modifiable factors such as sepsis.</p>","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"42 3","pages":"252-262"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary mycosis caused by Papiliotrema laurentii following COVID-19 infection: case report. COVID-19感染后劳伦乳头状孔虫致肺真菌病1例。
IF 1 Q3 Medicine Pub Date : 2025-12-01 DOI: 10.17843/rpmesp.2025.423.14970
Josué M Flores-Espejo, Roger A Sernaqué-Mechato

Papiliotrema laurentii (formerly known as Cryptococcus laurentii) is an environmental saprophytic yeast that rarely causes disease in humans, mainly in immunosuppressed patients. We present a case of nosocomial pulmonary mycosis due to Papiliotrema laurentii in a 51-year-old male patient with a COVID-19 infection and a history of untreated type 2 diabetes mellitus. During his hospital stay, he received intravenous fluconazole for two weeks, with a favorable outcome. He was discharged with oral fluconazole for three months and follow-up in an outpatient clinic. One month after hospital discharge, he presented with cardiorespiratory arrest that did not respond to resuscitation maneuvers. The case highlights the importance of considering saprophytic species among the differential diagnoses of opportunistic mycoses.

laurentii Papiliotrema laurentii(以前称为laurenti隐球菌)是一种环境腐生酵母,很少引起人类疾病,主要发生在免疫抑制患者中。我们报告一例由劳伦氏乳头状孔虫引起的院内性肺真菌病,患者为51岁男性,感染COVID-19并有未经治疗的2型糖尿病病史。在住院期间,他静脉注射氟康唑两周,结果良好。出院时口服氟康唑3个月,并在门诊随访。出院一个月后,他出现了心肺骤停,对复苏没有反应。该病例强调了在机会性真菌病的鉴别诊断中考虑腐生菌种的重要性。
{"title":"Pulmonary mycosis caused by Papiliotrema laurentii following COVID-19 infection: case report.","authors":"Josué M Flores-Espejo, Roger A Sernaqué-Mechato","doi":"10.17843/rpmesp.2025.423.14970","DOIUrl":"10.17843/rpmesp.2025.423.14970","url":null,"abstract":"<p><p>Papiliotrema laurentii (formerly known as Cryptococcus laurentii) is an environmental saprophytic yeast that rarely causes disease in humans, mainly in immunosuppressed patients. We present a case of nosocomial pulmonary mycosis due to Papiliotrema laurentii in a 51-year-old male patient with a COVID-19 infection and a history of untreated type 2 diabetes mellitus. During his hospital stay, he received intravenous fluconazole for two weeks, with a favorable outcome. He was discharged with oral fluconazole for three months and follow-up in an outpatient clinic. One month after hospital discharge, he presented with cardiorespiratory arrest that did not respond to resuscitation maneuvers. The case highlights the importance of considering saprophytic species among the differential diagnoses of opportunistic mycoses.</p>","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"42 3","pages":"323-327"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679970/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe thrombocytopenia following exposure to orlistat, alkylphenol, and pyrethroids: coincidence or causation? 暴露于奥利司他、烷基酚和拟除虫菊酯后的严重血小板减少症:巧合还是因果关系?
IF 1 Q3 Medicine Pub Date : 2025-12-01 DOI: 10.17843/rpmesp.2025.423.14626
Anais Zapata-Rafael, Johan Azañero-Haro, Alonso Soto
{"title":"Severe thrombocytopenia following exposure to orlistat, alkylphenol, and pyrethroids: coincidence or causation?","authors":"Anais Zapata-Rafael, Johan Azañero-Haro, Alonso Soto","doi":"10.17843/rpmesp.2025.423.14626","DOIUrl":"10.17843/rpmesp.2025.423.14626","url":null,"abstract":"","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"42 3","pages":"331-332"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The social imaginary in the daily lives of family caregivers during the prevention of childhood tuberculosis in southern Lima, Peru. 秘鲁利马南部儿童结核病预防期间家庭照顾者日常生活中的社会想象。
IF 1 Q3 Medicine Pub Date : 2025-12-01 DOI: 10.17843/rpmesp.2025.423.14430
Jhon Alex Zeladita-Huaman, Rosane Gonçalves Nitschke, María Josefa Arcaya-Moncada, Gladys Carmela Santos-Falcón, Roberto Zegarra-Chapoñan, Maria Lígia Dos Reis Bellaguarda

Objective.: To interpret the social imaginary of family caregivers regarding the daily practices of preventive tuberculosis therapy in children.

Materials and methods.: A qualitative, descriptive-interpretive study, from the perspective of comprehensive and everyday sociology. Fifteen caregivers of children who started preventive tuberculosis therapy in four health facilities in South Lima were interviewed between December 2020 and May 2021. The in-depth interview was used as a technique, and a virtual interview guide as the instrument. The analysis was conducted using the thematic analysis technique.

Results.: Three themes emerged: identifying strengths and limits in coping with tuberculosis; the impact of the social imaginary on sensitive care practices during preventive treatment; and interpreting the social construction of TB and its preventive practices.

Conclusions.: Strengths and limits were evidenced in the daily lives of caregivers while coping with and preventing tuberculosis. Likewise, in their sociability, they provided sensitive care based on their experiences, beliefs, feelings, and social bonds; they showed relative sensitivity and creativity in the face of the imposition of clinical rationalism. Furthermore, it was found that their ordinary knowledge and understanding of the disease were mediated by fears, uncertainties, and beliefs. Finally, their capacity to interpret and give meaning to the lived experience of the other is highlighted.

目标。解读家庭照顾者对儿童结核病预防治疗日常实践的社会想象。材料和方法。从综合社会学和日常社会学的角度进行定性、描述性和解释性的研究。2020年12月至2021年5月期间,对在南利马四家卫生机构开始预防性结核病治疗的15名儿童护理人员进行了访谈。采用深度访谈作为技术手段,虚拟访谈指南作为工具。分析采用专题分析技术进行。结果:出现了三个主题:确定应对结核病的优势和限制;预防治疗过程中社会想象对敏感护理实践的影响结论:在护理人员应对和预防结核病的日常生活中,优势和局限性得到了证明。同样,在他们的社交能力方面,他们根据自己的经历、信仰、感受和社会关系提供敏感的照顾;面对强加于人的临床理性主义,他们表现出了相对的敏感性和创造性。此外,研究发现,他们对疾病的普通知识和理解是由恐惧、不确定性和信念介导的。最后,他们对他人生活经验的解读和赋予意义的能力得到了强调。
{"title":"The social imaginary in the daily lives of family caregivers during the prevention of childhood tuberculosis in southern Lima, Peru.","authors":"Jhon Alex Zeladita-Huaman, Rosane Gonçalves Nitschke, María Josefa Arcaya-Moncada, Gladys Carmela Santos-Falcón, Roberto Zegarra-Chapoñan, Maria Lígia Dos Reis Bellaguarda","doi":"10.17843/rpmesp.2025.423.14430","DOIUrl":"10.17843/rpmesp.2025.423.14430","url":null,"abstract":"<p><strong>Objective.: </strong>To interpret the social imaginary of family caregivers regarding the daily practices of preventive tuberculosis therapy in children.</p><p><strong>Materials and methods.: </strong>A qualitative, descriptive-interpretive study, from the perspective of comprehensive and everyday sociology. Fifteen caregivers of children who started preventive tuberculosis therapy in four health facilities in South Lima were interviewed between December 2020 and May 2021. The in-depth interview was used as a technique, and a virtual interview guide as the instrument. The analysis was conducted using the thematic analysis technique.</p><p><strong>Results.: </strong>Three themes emerged: identifying strengths and limits in coping with tuberculosis; the impact of the social imaginary on sensitive care practices during preventive treatment; and interpreting the social construction of TB and its preventive practices.</p><p><strong>Conclusions.: </strong>Strengths and limits were evidenced in the daily lives of caregivers while coping with and preventing tuberculosis. Likewise, in their sociability, they provided sensitive care based on their experiences, beliefs, feelings, and social bonds; they showed relative sensitivity and creativity in the face of the imposition of clinical rationalism. Furthermore, it was found that their ordinary knowledge and understanding of the disease were mediated by fears, uncertainties, and beliefs. Finally, their capacity to interpret and give meaning to the lived experience of the other is highlighted.</p>","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"42 3","pages":"271-280"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679975/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of covid-19 in miners and former miners with a history of silicosis. 有矽肺病史的矿工和前矿工covid-19的特征
IF 1 Q3 Medicine Pub Date : 2025-12-01 DOI: 10.17843/rpmesp.2025.423.14698
Luis Guillermo Farmer-Aldunce, Ana María Salazar Bugueño, Marisol Concha-Barrientos, Gustavo Contreras Tudela, Olivia Janett Horna-Campos

During the SARS-CoV-2 pandemic, it was suggested that individuals with chronic lung diseases, such as silicosis, could be at increased risk of complications; however, the evidence remains limited. This study describes the prevalence of COVID-19 among 51 miners and former miners with silicosis who were part of an occupational surveillance program. 96% were over 60 years old, 37.2% had moderate or severe silicosis, and 67% had at least one comorbidity. The prevalence of COVID-19 was 15.7%, lower than the general population, with mild cases and no reported deaths. 94.1% had received at least two doses of vaccine; of these, 12.5% were affected by COVID-19, compared to 66.7% of those who were not vaccinated. These findings suggest that vaccination and preventive measures may have contributed to reduce transmission and severity, highlighting the importance of maintaining protection for individuals with chronic respiratory diseases.

在SARS-CoV-2大流行期间,有人认为患有慢性肺部疾病(如矽肺病)的人患并发症的风险可能会增加;然而,证据仍然有限。本研究描述了51名患有矽肺的矿工和前矿工中COVID-19的流行情况,这些矿工是职业监测计划的一部分。96%的患者年龄超过60岁,37.2%的患者有中度或重度矽肺,67%的患者至少有一种合并症。新冠肺炎流行率为15.7%,低于普通人群,病例轻症,无死亡报告。94.1%接种过至少两剂疫苗;其中,12.5%的人感染了COVID-19,而未接种疫苗的人感染了66.7%。这些发现表明,疫苗接种和预防措施可能有助于减少传播和严重程度,突出了对慢性呼吸道疾病患者保持保护的重要性。
{"title":"Characteristics of covid-19 in miners and former miners with a history of silicosis.","authors":"Luis Guillermo Farmer-Aldunce, Ana María Salazar Bugueño, Marisol Concha-Barrientos, Gustavo Contreras Tudela, Olivia Janett Horna-Campos","doi":"10.17843/rpmesp.2025.423.14698","DOIUrl":"10.17843/rpmesp.2025.423.14698","url":null,"abstract":"<p><p>During the SARS-CoV-2 pandemic, it was suggested that individuals with chronic lung diseases, such as silicosis, could be at increased risk of complications; however, the evidence remains limited. This study describes the prevalence of COVID-19 among 51 miners and former miners with silicosis who were part of an occupational surveillance program. 96% were over 60 years old, 37.2% had moderate or severe silicosis, and 67% had at least one comorbidity. The prevalence of COVID-19 was 15.7%, lower than the general population, with mild cases and no reported deaths. 94.1% had received at least two doses of vaccine; of these, 12.5% were affected by COVID-19, compared to 66.7% of those who were not vaccinated. These findings suggest that vaccination and preventive measures may have contributed to reduce transmission and severity, highlighting the importance of maintaining protection for individuals with chronic respiratory diseases.</p>","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"42 3","pages":"318-322"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and evaluation of loop-mediated isothermal amplification (lamp) for rapid detection of campylobacter jejuni. 空肠弯曲杆菌环介导等温扩增快速检测技术的建立与评价。
IF 1 Q3 Medicine Pub Date : 2025-12-01 DOI: 10.17843/rpmesp.2025.423.14501
Junior Caro-Castro, Fiorella Orellana-Peralta, Diana Flores-León, Evans Cucho-Meza, Ronnie G Gavilán, Willi Quino

Objectives.: To develop and evaluate a loop-mediated isothermal amplification (LAMP) assay for the rapid detection of Campylobacter jejuni in stool samples associated with acute diarrheal disease (ADD) and Guillain-Barré syndrome (GBS) for implementation in regional laboratories and primary health care centers.

Materials and methods.: Four sets of LAMP primers for C. jejuni were designed and initially evaluated with DNA from C. jejuni, Campylobacter coli, Salmonella Infantis, and Escherichia coli extracted using a commercial kit. The best-performing primer set was selected for assay optimization, determination of the limit of detection, and analytical validation with DNA from the aforementioned strains. Subsequently, clinical validation was performed using stool samples from patients with suspected ADD due to C. jejuni, applying the same standardized conditions used for the strain DNA samples. The sensitivity and specificity of the test were determined using real-time PCR (qPCR) as the standard.

Results.: The LAMP assay for the detection of C. jejuni in stool samples using a primer set for the cdtC region showed a sensitivity of 97% (CI: 81.49-99.83%), a specificity of 93% (CI: 75.79-98.80%), a positive predictive value of 94% (CI: 77.78-98.91%), and a negative predictive value of 96% (CI: 79.76-99.81%). Furthermore, a strong agreement was demonstrated between this LAMP assay and qPCR (k=0.9).

Conclusions.: The LAMP assay based on the cdtC gene is a reliable and rapid method, with high sensitivity and specificity comparable to qPCR for the identification of C. jejuni associated with ADD and GBS, especially in low-resource areas, due to its low cost and ease of implementation.

目标。开发和评估一种环介导的等温扩增(LAMP)方法,用于快速检测与急性腹泻病(ADD)和格林-巴勒综合征(GBS)相关的粪便样本中的空肠弯曲杆菌,以便在地区实验室和初级卫生保健中心实施。材料和方法。设计了四套空肠梭菌LAMP引物,并使用商用试剂盒提取空肠梭菌、大肠弯曲杆菌、婴儿沙门氏菌和大肠杆菌的DNA进行初步评价。选择性能最好的引物进行分析优化、检测限测定和上述菌株DNA分析验证。随后,使用疑似空肠梭菌引起的ADD患者的粪便样本进行临床验证,采用与菌株DNA样本相同的标准化条件。测试的敏感性和特异性测定使用实时PCR (qPCR)作为standard.Results。c .空肠的灯试验检测粪便样本通过一组引物cdtC地区显示97% (-99.83% CI: 81.49)的敏感性,特异性为93% (-98.80% CI: 75.79),阳性预测值94% (-98.91% CI: 77.78),和一个负面预测值的96% (-99.81% CI: 79.76)。此外,LAMP试验和qPCR之间的一致性很强(k=0.9)。基于cdtC基因的LAMP检测是一种可靠、快速的方法,具有可与qPCR相比较的高灵敏度和特异性,特别是在低资源地区,由于其成本低且易于实施,因此可用于鉴定与ADD和GBS相关的空肠梭菌。
{"title":"Development and evaluation of loop-mediated isothermal amplification (lamp) for rapid detection of campylobacter jejuni.","authors":"Junior Caro-Castro, Fiorella Orellana-Peralta, Diana Flores-León, Evans Cucho-Meza, Ronnie G Gavilán, Willi Quino","doi":"10.17843/rpmesp.2025.423.14501","DOIUrl":"10.17843/rpmesp.2025.423.14501","url":null,"abstract":"<p><strong>Objectives.: </strong>To develop and evaluate a loop-mediated isothermal amplification (LAMP) assay for the rapid detection of Campylobacter jejuni in stool samples associated with acute diarrheal disease (ADD) and Guillain-Barré syndrome (GBS) for implementation in regional laboratories and primary health care centers.</p><p><strong>Materials and methods.: </strong>Four sets of LAMP primers for C. jejuni were designed and initially evaluated with DNA from C. jejuni, Campylobacter coli, Salmonella Infantis, and Escherichia coli extracted using a commercial kit. The best-performing primer set was selected for assay optimization, determination of the limit of detection, and analytical validation with DNA from the aforementioned strains. Subsequently, clinical validation was performed using stool samples from patients with suspected ADD due to C. jejuni, applying the same standardized conditions used for the strain DNA samples. The sensitivity and specificity of the test were determined using real-time PCR (qPCR) as the standard.</p><p><strong>Results.: </strong>The LAMP assay for the detection of C. jejuni in stool samples using a primer set for the cdtC region showed a sensitivity of 97% (CI: 81.49-99.83%), a specificity of 93% (CI: 75.79-98.80%), a positive predictive value of 94% (CI: 77.78-98.91%), and a negative predictive value of 96% (CI: 79.76-99.81%). Furthermore, a strong agreement was demonstrated between this LAMP assay and qPCR (k=0.9).</p><p><strong>Conclusions.: </strong>The LAMP assay based on the cdtC gene is a reliable and rapid method, with high sensitivity and specificity comparable to qPCR for the identification of C. jejuni associated with ADD and GBS, especially in low-resource areas, due to its low cost and ease of implementation.</p>","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"42 3","pages":"263-270"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12679974/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista Peruana de Medicina de Experimental y Salud Publica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1